The challenge of continuously raising prostate cancer awareness
Staying alive
Related Posts
Nxera unveils proprietary pipeline targeting obesity and metabolic disorders
New oral GLP-1 agonist aims to reshape chronic weight management Nxera Pharma has launched a broad proprietary pipeline focused on next-generation therapies for obesity and […]
Prostate cancer focal therapy could improve costs and patient outcomes
Every year, over 44,000 men are diagnosed with prostate cancer in England A study led by the National Institute for Health and […]
A rare opportunity – PharmaTimes
Importance of continuous collaboration with rare disease communities At Blueprint Medicines, we aim to make a significant difference in patients’ lives by solving critical medical […]